CLINICAL_TRIALS
trial_result
· 2025-01-30
Clinical Trial Update: T2 FSL2 Weight Loss
Summary
Abbott Diabetes Care's T2 FSL2 Weight Loss trial in Type 2 diabetes mellitus has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott Diabetes Care | Conditions: Diabetes Mellitus, Type 2 | Status: TERMINATED